Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.31 USD | -1.77% | +0.53% | -11.27% |
May. 14 | Oppenheimer Lowers UroGen Pharma Price Target to $32 From $34, Maintains Outperform Rating | MT |
May. 13 | Transcript : UroGen Pharma Ltd., Q1 2024 Earnings Call, May 13, 2024 |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Bearish | Neutral |
Resistance | 14.53 | 15.10 | 22.61 |
Spread/Res. | -8.40% | -11.85% | -41.13% |
Spread/Supp. | +4.47% | +4.47% | +44.83% |
Support | 12.74 | 12.74 | 9.190 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- URGN Stock
- Charts UroGen Pharma Ltd.